News Minimalist logo

New malaria vaccines R21 and RTS,S show promise

The Conversation — April 24, 2024, 03:00 PM UTC

Summary: Two malaria vaccines, RTS,S and R21, have been developed in the last three years. The R21/Matrix-M vaccine targets sporozoites to prevent malaria transmission. Children under five are most vulnerable to malaria, with a child dying every minute in Africa. The R21 vaccine costs US$3.90 per dose and could help reduce malaria deaths from 600,000 to 200,000 annually by the end of the decade. Malaria eradication worldwide is projected for the 2030s.

Full article

Article metrics
Significance6.6
Scale8.0
Magnitude7.5
Potential8.5
Novelty7.0
Actionability6.0
Immediacy9.0
Positivity8.0
Credibility9.0

Timeline:

  1. [5.2]
    African countries roll out malaria vaccine, new baby treatment (Health Policy Watch)
    19d
    Source
  2. [4.8]
    Benin, Liberia, Sierra Leone launch malaria vaccine programs in Africa (Voice of America - VOA News)
    23d
    Source
  3. [5.8]
    Malaria cases rose, Africa hit hardest, vaccines show promise (The Hindu)
    24d

    ScoresSource
  4. [5.0]
    New malaria vaccines developed; R21 targets sporozoites, aids control (AllAfrica - Top Africa News)
    24d
    Source
  5. [6.7]
    Malaria vaccines show promise in Africa's fight against disease (The Conversation)
    27d

    ScoresSource